Literature DB >> 11578769

Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.

J G Sheng1, R A Jones, X Q Zhou, J M McGinness, L J Van Eldik, R E Mrak, W S Griffin.   

Abstract

Activated (phosphorylated) mitogen-activated protein kinase p38 (MAPK-p38) and interleukin-1 (IL-1) have both been implicated in the hyperphosphorylation of tau, a major component of the neurofibrillary tangles in Alzheimer's disease. This, together with findings showing that IL-1 activates MAPK-p38 in vitro and is markedly overexpressed in Alzheimer brain, suggest a role for IL-1-induced MAPK-p38 activation in the genesis of neurofibrillary pathology in Alzheimer's disease. We found frequent colocalization of hyperphosphorylated tau protein (AT8 antibody) and activated MAPK-p38 in neurons and in dystrophic neurites in Alzheimer brain, and frequent association of these structures with activated microglia overexpressing IL-1. Tissue levels of IL-1 mRNA as well as of both phosphorylated and non-phosphorylated isoforms of tau were elevated in these brains. Significant correlations were found between the numbers of AT8- and MAPK-p38-immunoreactive neurons, and between the numbers of activated microglia overexpressing IL-1 and the numbers of both AT8- and MAPK-p38-immunoreactive neurons. Furthermore, rats bearing IL-1-impregnated pellets showed a six- to seven-fold increase in the levels of MAPK-p38 mRNA, compared with rats with vehicle-only pellets (P<0.0001). These results suggest that microglial activation and IL-1 overexpression are part of a feedback cascade in which MAPK-p38 overexpression and activation leads to tau hyperphosphorylation and neurofibrillary pathology in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578769      PMCID: PMC3833633          DOI: 10.1016/s0197-0186(01)00041-9

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  22 in total

1.  Reactivating kinase/p38 phosphorylates tau protein in vitro.

Authors:  C H Reynolds; A R Nebreda; G M Gibb; M A Utton; B H Anderton
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

Review 2.  Mitogen-activated protein kinase cascades and regulation of gene expression.

Authors:  B Su; M Karin
Journal:  Curr Opin Immunol       Date:  1996-06       Impact factor: 7.486

3.  p38 kinase is activated in the Alzheimer's disease brain.

Authors:  K Hensley; R A Floyd; N Y Zheng; R Nael; K A Robinson; X Nguyen; Q N Pye; C A Stewart; J Geddes; W R Markesbery; E Patel; G V Johnson; G Bing
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

4.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205.

Authors:  M Goedert; R Jakes; E Vanmechelen
Journal:  Neurosci Lett       Date:  1995-04-21       Impact factor: 3.046

Review 5.  Towards an understanding of the signal transduction pathways for interleukin 1.

Authors:  L A O'Neill
Journal:  Biochim Biophys Acta       Date:  1995-04-06

6.  Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.

Authors:  J G Sheng; R E Mrak; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1997-03       Impact factor: 3.685

7.  p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta.

Authors:  Z Guan; L D Baier; A R Morrison
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

8.  Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: implications for MAP kinase activation in Alzheimer disease.

Authors:  R B Knowles; J Chin; C T Ruff; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1999-10       Impact factor: 3.685

9.  Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine.

Authors:  J Raingeaud; S Gupta; J S Rogers; M Dickens; J Han; R J Ulevitch; R J Davis
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

Review 10.  Glial cytokines in Alzheimer's disease: review and pathogenic implications.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

View more
  56 in total

1.  Regulation of tau pathology by the microglial fractalkine receptor.

Authors:  Kiran Bhaskar; Megan Konerth; Olga N Kokiko-Cochran; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb
Journal:  Neuron       Date:  2010-10-06       Impact factor: 17.173

2.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

3.  Tau as a drug target in Alzheimer's disease.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

4.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Shanya Jiang; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Brain       Date:  2015-03-31       Impact factor: 13.501

Review 5.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

6.  Age-associated alterations in the time-dependent profile of pro- and anti-inflammatory proteins within the hippocampus in response to acute exposure to interleukin-1β.

Authors:  Sarah C Hopp; Sarah Royer; Holly M Brothers; Roxanne M Kaercher; Heather D'Angelo; Isabelle Bardou; Gary L Wenk
Journal:  J Neuroimmunol       Date:  2013-12-22       Impact factor: 3.478

7.  CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease.

Authors:  Michele Salemi; Pier Franco Soma; Paolo Bosco; Enzo Vicari; Roberto Castiglione; Castiglione Roberto; Aldo E Calogero
Journal:  Hum Cell       Date:  2013-06-18       Impact factor: 4.174

Review 8.  Targeting protein kinases in central nervous system disorders.

Authors:  Laura K Chico; Linda J Van Eldik; D Martin Watterson
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

9.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

Authors:  Jaewon Lee; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 10.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.